Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
|
|
NANOPHASE TECHNOLOGIES Corp (NANX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/02/2023 |
8-K
| Quarterly results |
| 05/11/2023 |
8-K
| Quarterly results |
| 05/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 03/29/2023 |
8-K
| Quarterly results |
| 11/08/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 08/17/2022 |
8-K
| Quarterly results |
| 05/11/2022 |
8-K
| Quarterly results |
| 03/31/2022 |
8-K
| Quarterly results |
| 02/02/2022 |
8-K
| Quarterly results |
| 12/09/2021 |
8-K
| Quarterly results |
| 11/03/2021 |
8-K
| Quarterly results |
| 08/17/2021 |
8-K
| Quarterly results |
| 08/16/2021 |
8-K
| Quarterly results |
| 06/14/2021 |
8-K
| Quarterly results |
| 04/27/2021 |
8-K
| Quarterly results |
| 04/21/2021 |
8-K
| Quarterly results |
| 03/11/2021 |
8-K
| Quarterly results |
| 12/23/2020 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 11/03/2020 |
8-K
| Quarterly results|
Docs:
|
"Nanophase Reports Record Third Quarter 2020 Financial Results as Solésence Expands Beauty Footprint Announces 20+% Growth and Record Profitability ROMEOVILLE, Ill., Nov. 03, 2020 -- Nanophase Technologies Corporation , a leader in minerals-based and scientifically-driven health care innovations across various beauty and life science categories, protecting skin from environmental aggressors and aiding in medical diagnostics, today reported financial results for the three- and nine-month periods ended September 30, 2020. Jess Jankowski, President and CEO, commented: “the third quarter continued our strong progress in profitably growing Nanophase. Our medical diagnostics materials for Covid-19-related applications continue to receive broad use during the global pandemic, while our fully formu..." |
|
| 10/30/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Laura M. Beres Joins Nanophase Board of Directors as Solésence Expands Beauty Footprint ROMEOVILLE, Ill., Oct. 29, 2020 -- Nanophase Technologies Corporation , a leader in minerals-based and scientifically-driven health care innovations across beauty and life science categories, is pleased to announce the appointment of Laura M. Beres to its Board of Directors. Beres is director of corporate strategy at Ulta Beauty, the nation’s leading beauty retailer that operates more than 1,200 stores across 50 states. Beres leads Conscious Beauty at Ulta Beauty, a holistic program that offers enhanced transparency and choice around clean ingredients and sustainability. “I’m thrilled to join the board of directors for Nanophase as it moves into the next chapter of its exciting journey,” says Beres, who..." |
|
| 09/21/2020 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 09/02/2020 |
8-K
| Quarterly results |
| 08/06/2020 |
8-K
| Quarterly results |
| 04/29/2020 |
8-K
| Quarterly results|
Docs:
|
"Nanophase Reports First Quarter 2020 Financial Results Announces 8% Growth for Quarter, Outsized Formulated Product Sales ROMEOVILLE, Ill., April 29, 2020 -- Nanophase Technologies Corporation , a leader in minerals-based personal care ingredients and formulated products for protecting skin from environmental aggressors, such as UV light and pollution, today reported financial results for the first quarter period ended March 31, 2020. “Even with the struggles brought on by Covid-19 and the related quarantine, there are reasons for optimism for Nanophase and Solésence,” commented Jess Jankowski, President and CEO. “We continue to operate as an essential service, and have more than doubled our capacity for producing materials for medical diagnostic applications by reconfiguring our manufactu..." |
|
| 04/21/2020 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 03/31/2020 |
8-K
| Quarterly results|
Docs:
|
"Nanophase Reports 2019 Revenue Solésence Performs Well, First Half 2020 Outlook Positive ROMEOVILLE, Ill., March 31, 2020 -- Nanophase Technologies Corporation , a leader in minerals-based personal care ingredients and formulated products for protecting skin from environmental aggressors, such as UV light and pollution, today reported financial results for the fourth quarter and fiscal year ended December 31, 2019. “Nanophase and Solésence continue to move forward during this difficult time for all of us,” said Jess Jankowski, President and CEO of both companies. “We are taking necessary precautions to protect our employees, their families, and our community during this disruption, while continuing to manufacture products and ingredients within sectors that are part of our nation’s critica..." |
|
| 01/14/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/22/2019 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 11/14/2019 |
8-K
| Quarterly results |
| 08/28/2019 |
8-K
| Quarterly results |
| 08/02/2019 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 05/15/2019 |
8-K
| Quarterly results |
| 04/11/2019 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 03/27/2019 |
8-K
| Quarterly results |
|
|
|